William Fricker

William Fricker

Geen lopende functies
63 jaar
Health Technology
Consumer Services
Process Industries

Profiel

William Fricker formerly worked at Immunomedics, Inc., as Controller from 2018 to 2020, Eleison Pharmaceuticals, Inc., as Chief Financial Officer from 2022 to 2023, NRX Pharmaceuticals, Inc., as Chief Financial Officer & Treasurer in 2021, J.
M.
Huber Micropowders, Inc., as VP, Global Controller & Chief Accounting Officer, NeuroTrauma Sciences LLC, as Chief Financial Officer from 2023 to 2024, and Annovis Bio, Inc., as Chief Financial Officer from 2024 to 2025.
Mr. Fricker received his undergraduate degree from The Pennsylvania State University.

Eerdere bekende functies van William Fricker

BedrijvenFunctieEinde
ANNOVIS BIO, INC. Financieel Directeur/CFO 27-03-2025
Financieel Directeur/CFO 01-04-2024
Financieel Directeur/CFO 01-01-2023
NRX PHARMACEUTICALS, INC. Financieel Directeur/CFO 30-08-2021
IMMUNOMEDICS, INC. Comptroller/Controller/Auditor 01-10-2020
Ervaring van William Fricker in detail bekijken

Opleiding van William Fricker

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

2

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Process Industries

  1. Beurs
  2. Insiders
  3. William Fricker